allidochlor

We are allidochlor CAS:93-71-0 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:allidochlor
CAS.NO:93-71-0
Synonyms:allidochlor
2-chloro-N,N-di-2-propen-1-ylacetamide
2-chloro-N,N-di(prop-2-en-1-yl)acetamide
CDAA
Acetamide, 2-chloro-N,N-di-2-propenyl-
2-Chloro-N,N-Diallylacetamide
Molecular Formula:C8H12ClNO
Molecular Weight:173.64000
 
Physical and Chemical Properties:
Density:1.042
Melting point:145ºC
Boiling point:241.5ºC
Flash point:99.8ºC
Index of Refraction:1.478
 
Specification:
Appearance:Amber oily liquid
Assay:≥99.0%
 
Packing:200 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:For selective pre-emergence soil treatment herbicide

allidochlor


Related News: “Our collaboration with Mankind demonstrates our commitment towards providing novel, innovative treatment options for efficient diabetes management,” Glenmark Pharmaceuticals President, India Formulations, Middle East and Africa Sujesh Vasudevan said.Tetrafluoroborato de 2-bromo-1-etilpiridinio CAS:878-23-9 Profitability continued to improve. The company’s comprehensive gross profit margin for the first three quarters was 36.06%, a year-on-year increase of 3.44 percentage points. Since this year, the company’s profitability has remained at a relatively high level. On the one hand, due to the decline in the trading business with lower profitability, the proportion has declined.82671-02-1 Rigosertib is a small molecule that inhibits cellular signaling in cancer cells by acting as a RAS mimetic. Current clinical development of rigosertib is centered upon the therapeutic management of MDS, a heterogeneous group of bone marrow disorders characterized by ineffective hematopoiesis that often develop into acute myeloid leukaemia (AML).1214369-42-2 GlaxoSmithKline’s HIV drugs division ViiV Healthcare said on Saturday that the U.S. Food and Drug Administration declined to approve its long acting HIV injection.Jo Soden, Co-managing Director of Retrogenix, said “We look forward to working with Resonant to deconvolute the targets for their antibodies. Resonant’s innovative platform is delivering functional therapeutic candidates at rapid pace and we welcome the opportunity to identify the specific, biologically-relevant targets which will help progress these leads towards promising new therapies for patients with cancer.”

Related Products
Product Name
2-(Trifluoromethyl)thioxanthen-9-one View Details
4-Bromo-3-methylbenzoic acid View Details
(3-Phenoxyphenyl)methanol View Details
(2-Chloro-5-iodophenyl)[4-[[(3S)-tetrahydro-3-furanyl]oxy]phenyl]methanone manufacturer thiouracil manufacturer 4-Bromo-4′-iodo-1,1′-biphenyl manufacturer (S)-2-((S)-4-methyl-2-((S)-2-(2-morpholinoacetamido)-4-phenylbutanamido)pentanamido)-3-phenyipropanoic acid manufacturer Gonadorelin acetate manufacturer